180 related articles for article (PubMed ID: 21474432)
1. Targeting eosinophil biology in asthma therapy.
Wegmann M
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):667-74. PubMed ID: 21474432
[TBL] [Abstract][Full Text] [Related]
2. Verdict in the case of therapies versus eosinophils: the jury is still out.
Bochner BS
J Allergy Clin Immunol; 2004 Jan; 113(1):3-9; quiz 10. PubMed ID: 14713900
[TBL] [Abstract][Full Text] [Related]
3. Eosinophil apoptosis as a therapeutic target in allergic asthma.
Ilmarinen P; Kankaanranta H
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):109-17. PubMed ID: 24148899
[TBL] [Abstract][Full Text] [Related]
4. Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a.
Munitz A; Bachelet I; Levi-Schaffer F
J Allergy Clin Immunol; 2006 Nov; 118(5):1082-9. PubMed ID: 17088133
[TBL] [Abstract][Full Text] [Related]
5. Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation.
Hahn C; Islamian AP; Renz H; Nockher WA
J Allergy Clin Immunol; 2006 Apr; 117(4):787-94. PubMed ID: 16630935
[TBL] [Abstract][Full Text] [Related]
6. Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model.
Lee MY; Seo CS; Lee NH; Ha H; Lee JA; Lee H; Lee KY; Shin HK
Int Immunopharmacol; 2010 Nov; 10(11):1374-9. PubMed ID: 20727999
[TBL] [Abstract][Full Text] [Related]
7. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma.
Noga O; Hanf G; Brachmann I; Klucken AC; Kleine-Tebbe J; Rosseau S; Kunkel G; Suttorp N; Seybold J
J Allergy Clin Immunol; 2006 Jun; 117(6):1493-9. PubMed ID: 16751018
[TBL] [Abstract][Full Text] [Related]
8. Targeting of eosinophils in asthma.
Molfino NA
Expert Opin Biol Ther; 2012 Jul; 12(7):807-9. PubMed ID: 22500988
[TBL] [Abstract][Full Text] [Related]
9. What's new in asthma pathophysiology and immunopathology?
Orihara K; Dil N; Anaparti V; Moqbel R
Expert Rev Respir Med; 2010 Oct; 4(5):605-29. PubMed ID: 20923340
[TBL] [Abstract][Full Text] [Related]
10. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms in allergic airway inflammation - lessons from studies in the mouse.
Shum BO; Rolph MS; Sewell WA
Expert Rev Mol Med; 2008 May; 10():e15. PubMed ID: 18503727
[TBL] [Abstract][Full Text] [Related]
12. Understanding the pathogenesis of allergic asthma using mouse models.
Leong KP; Huston DP
Ann Allergy Asthma Immunol; 2001 Aug; 87(2):96-109; quiz 110,. PubMed ID: 11527255
[TBL] [Abstract][Full Text] [Related]
13. [Eosinophilic granulocytes and their significance in allergic diseases].
Bruijnzeel PL; Rihs S; Betz S
Schweiz Med Wochenschr; 1992 Feb; 122(6):173-80. PubMed ID: 1535993
[TBL] [Abstract][Full Text] [Related]
14. Benefits of induced sputum for the evaluation of therapeutic efficacy in patients with bronchial asthma.
Ohnishi H; Maeda H; Nishimura Y; Yokoyama M
Kobe J Med Sci; 1998 Aug; 44(4):149-61. PubMed ID: 10352494
[TBL] [Abstract][Full Text] [Related]
15. [Role of monoclonal anti-IgE antibodies (rhu-MAb) in the treatment of allergic bronchial asthma].
Targowski T; From S
Pol Merkur Lekarski; 2003 Jan; 14(79):65-8. PubMed ID: 12712834
[TBL] [Abstract][Full Text] [Related]
16. Targeting interleukin (IL) 5 for asthma and hypereosinophilic diseases.
Stein ML; Munitz A
Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):201-9. PubMed ID: 20807192
[TBL] [Abstract][Full Text] [Related]
17. [The roles of adhesion molecules, cytokines, and chemokines in eosinophil activation during allergic inflammation].
Chihara J
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():116-20. PubMed ID: 9216199
[TBL] [Abstract][Full Text] [Related]
18. Interaction of suplatast tosilate (IPD) with chloride channels in human blood eosinophils: a potential mechanism underlying its anti-allergic and anti-asthmatic effects.
Agrawal DK; Cheng G; Kim MJ; Kiniwa M
Clin Exp Allergy; 2008 Feb; 38(2):305-12. PubMed ID: 18028459
[TBL] [Abstract][Full Text] [Related]
19. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
[TBL] [Abstract][Full Text] [Related]
20. Eosinophils in asthma.
Busse WW; Sedgwick JB
Ann Allergy; 1992 Mar; 68(3):286-90. PubMed ID: 1546825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
